HHS Buys Next Generation Smallpox Vaccine

Armen Hareyan's picture
Advertisement

Smallpox Vaccine

HHS has awarded a contract for $500 million to Bavarian Nordic A/S of Copenhagen, Denmark to manufacture and deliver 20 million doses of a next generation modified vaccinia Ankara smallpox vaccine.

Advertisement

The vaccine would be recommended in the event of a smallpox outbreak to protect people in the United States who have weakened immune systems. The full supply of the vaccine will be added to the Strategic National Stockpile, a reserve of large quantities of medicine and medical supplies to protect the American public if there is a public health emergency.

"To protect ourselves from the remote but extremely grave threat of a deliberate release of smallpox virus, we need vaccines that can be safely given to all Americans, including individuals with weakened immune systems," Secretary Leavitt said. "Acquiring a stockpile of this new smallpox vaccine is a key step toward protecting even more members of the American public against a smallpox release."

As part of HHS' comprehensive strategy to address the public health threat of a smallpox outbreak, the Strategic National Stockpile currently contains sufficient smallpox vaccine for every American.

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.
Advertisement